American Airlines CEO Says Expect Five New Chicago Gates By End Of Year
https://event.webcasts.com/starthere.jsp?ei=1776260&tp_key=5a46116329&tp_special=8
Stocks · News reference
Shares of airline companies are trading higher amid a pullback in energy prices after reports suggesting that Pakistan and Iran are attempting to resume U.S.-Iran negotiations through a China-supported initiative.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
American Airlines CEO Says Feels "Really Good" About Q3 Revenue Guidance Of 16%-19% YoY Growth; Says Vast Majority Of Current Revenue Gains Can Be Retained, Expects Performance To Be Durable; Says Revenue Strength Broad-Based Across Domestic, International, Front Cabin And Coach; Says Airline Has Recaptured "A Tremendous Amount" Of Higher Fuel Expense Through Revenue; Says From A Co-Brand Perspective, We're Looking At Cash Regeneration Of About $8B This Year
https://event.webcasts.com/starthere.jsp?ei=1776260&tp_key=5a46116329&tp_special=8
American Airlines CEO Speaking At Morgan Stanley Conference Says Fuel Costs Have Climbed By Over $1B Heading Into Q4
https://event.webcasts.com/starthere.jsp?ei=1776260&tp_key=5a46116329&tp_special=8
American Airlines CEO Says As Fuel Stabilizes, It Eventually Will, Really Look To Us Being Back On Track, Producing Much Improved Margins, Producing FCF
https://event.webcasts.com/starthere.jsp?ei=1776260&tp_key=5a46116329&tp_special=8
Warren Buffett, Donald Trump Bet on Same 17 Stocks — Some Might Surprise You
The investment portfolio of President Donald Trump and Berkshire Hathaway have 17 stocks in common. Here's a look at the list.
This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters. Is It a No-Brainer Buy?
Stanley Druckenmiller's Duquesne family office has maintained Natera as its largest holding for 8 consecutive quarters. The medical diagnostics company uses liquid biopsy technology for cancer detection and other applications, showing strong growth with 57% year-over-year increase in oncology tests and 38% revenue growth. Despite persistent losses, the company has strong cash reserves and is projected to approach profitability by 2027. However, the stock has surged 87% in the past year with a lofty price-to-sales ratio of 17.